PCV53 IMPACT OF THE ANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEART ATTACK TRIAL (ALLHAT) ON PHYSICIAN PRESCRIBING PATTERNS AND PATIENT UTILIZATION OF ANTIHYPERTENSIVE MEDICATIONS

May 1, 2004, 00:00
10.1016/S1098-3015(10)62419-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)62419-9/fulltext
Title : PCV53 IMPACT OF THE ANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEART ATTACK TRIAL (ALLHAT) ON PHYSICIAN PRESCRIBING PATTERNS AND PATIENT UTILIZATION OF ANTIHYPERTENSIVE MEDICATIONS
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62419-9&doi=10.1016/S1098-3015(10)62419-9
First page :
Section Title :
Open access? : No
Section Order : 356
Categories :
Tags :
Regions :
ViH Article Tags :